推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

Translational Oncology

2023年12月最新中科院分区表数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 TRANSL ONCOL最新评论:绝对垃圾期刊,不要投。送审很快,一个月审稿结束,返修后意见小修,返回去后没有理由直接拒稿。浪费时间 (2024-03-25)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中科院分区:   是否OA期刊:   结果排序:

同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


Translational Oncology期刊基本信息Hello,您是该期刊的第60351位访客

基本信息 登录收藏
期刊名字Translational OncologyTranslational Oncology

TRANSL ONCOL
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
6.0
58人评分
我要评分

声誉
6.9

影响力
5.1

速度
6.8

期刊ISSN1936-5233
微信扫码收藏此期刊
2022-2023最新影响因子
(数据来源于搜索引擎)
5 点击查看影响因子趋势图
实时影响因子 截止2024年3月26日:4.399
2022-2023自引率2.00%点击查看自引率趋势图
五年影响因子4.6
h-index 41
CiteScore
CiteScoreSJRSNIPCiteScore排名
7.201.1501.035
学科分区排名百分位
大类:Medicine
小类:Oncology
Q295 / 366
大类:Medicine
小类:Cancer Research
Q287 / 214

期刊简介
Translational Oncology publishes the results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of oncology patients. Translational Oncology will publish laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer. Peer reviewed manuscript types include Original Reports, Reviews and Editorials.
期刊官方网站https://www.journals.elsevier.com/translational-oncology
期刊投稿网址https://www.editorialmanager.com/TRANON
期刊语言要求经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Translational Oncology的语言要求,还能让Translational Oncology编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Translational Oncology编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问Yes
OA期刊相关信息
文章处理费:需要( USD2930; )
文章处理费豁免:查看说明

其他费用:没有
期刊主题关键词:translational oncology、cancer、genetics、endocrinology、tumour
相关链接:Aims & ScopeAuthor InstructionsEditorial BoardPeer review
通讯方式NEOPLASIA PRESS, 1150 W MEDICAL CENTER DR, MSRB III, RM 9303, ANN ARBOR, USA, MI, 48109-0648
出版商Neoplasia Press
涉及的研究方向Biochemistry, Genetics and Molecular Biology-Cancer Research
出版国家或地区UNITED STATES
出版语言English
出版周期Quarterly
出版年份2007
年文章数 305点击查看年文章数趋势图
Gold OA文章占比95.80%
研究类文章占比:
文章 ÷(文章 + 综述)
97.38%
WOS期刊SCI分区
2022-2023年最新版
WOS分区等级:2区

按学科分区JIF分区JIF排名JIF百分位
学科:ONCOLOGY
类别:SCIE
Q277/241
中科院《国际期刊预警
名单(试行)》名单
2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中科院SCI期刊分区
2023年12月最新升级版
点击查看中科院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 2区2区2区
ONCOLOGY
肿瘤学
2区3区3区
中科院SCI期刊分区
2022年12月升级版
大类学科小类学科Top期刊综述期刊
医学 1区3区1区
ONCOLOGY
肿瘤学
3区2区3区
中科院SCI期刊分区
2021年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 1区3区2区
ONCOLOGY
肿瘤学
4区3区3区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
Directory of Open Access Journals (DOAJ)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1936-5233%5BISSN%5D
平均审稿速度网友分享经验:
较慢,6-12周
平均录用比例网友分享经验:
较易
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在Translational Oncology顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 Translational Oncology期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 Translational Oncology中科院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
Translational Oncology上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中科院SCI期刊分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发表论文
  • 中科院SCI期刊分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    Cancer Communications019.90
    CELLULAR ONCOLOGY010.40
    Frontiers in Oncology605.20
    Journal of Gastric Cancer225.20
    Molecular and Cellular Oncology03.00
    Clinical and Experimental Morphology00.40
    Critical Reviews in Oncogenesis02.50
    中科院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE607015
    BIOMATERIALS517734
    BIOMEDICINE & PHARMACOTHERAPY470063
    Journal of Materials Chemistry B463018
    Frontiers in Pharmacology454769
    Frontiers in Immunology426441
    JOURNAL OF ETHNOPHARMACOLOGY409722
    COLLOIDS AND SURFACES B-BIOINTERFACES406606
    Frontiers in Oncology387671
    Acta Biomaterialia379253
  •  

    Translational Oncology Translational Oncology
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Loss of BLK expression as a potential predictor of poor prognosis and immune checkpoint blockade response in NSCLC and contribute to tumor progression

    Author: Xu, Yingqi; Xu, Jianlin; Qiao, Rong; Zhong, Hua; Xia, Jinjing; Zhong, Runbo
    Journal: TRANSLATIONAL ONCOLOGY. 2023; Vol. 33, Issue , pp. -. DOI: 10.1016/j.tranon.2023.101671
        PubMed      DOI
    2.The roles of Linc-ROR in the regulation of cancer stem cells

    Author: Wen, Xiaoling; Wu, Yingying; Lou, Yanhui; Xia, Yufang; Yu, Xiao
    Journal: TRANSLATIONAL ONCOLOGY. 2023; Vol. 28, Issue , pp. -. DOI: 10.1016/j.tranon.2022.101602
        PubMed      DOI
    3.Immune microenvironment and therapeutic progress of recurrent hepatocellular carcinoma after liver transplantation

    Author: Jin, Xin; Ma, Xiaoting; Zhao, Dong; Yang, Lin; Ma, Nan
    Journal: TRANSLATIONAL ONCOLOGY. 2023; Vol. 28, Issue , pp. -. DOI: 10.1016/j.tranon.2022.101603
        PubMed      DOI
    4.circ-ZEB1 regulates epithelial-mesenchymal transition and chemotherapy resistance of colorectal cancer through acting on miR-200c-5p

    Author: Chen, Hongyu; Zhang, Jianwei; Yang, Lei; Li, Yansen; Wang, Zhenjun; Ye, Chunxiang
    Journal: TRANSLATIONAL ONCOLOGY. 2023; Vol. 28, Issue , pp. -. DOI: 10.1016/j.tranon.2022.101604
        PubMed      DOI
    5.Impact of coronavirus disease 2019 on lung cancer patients: A meta-analysis

    Author: Wang, Linlin; Wang, Ye; Cheng, Xianbin; Li, Xingzhao; Li, Jun
    Journal: TRANSLATIONAL ONCOLOGY. 2023; Vol. 28, Issue , pp. -. DOI: 10.1016/j.tranon.2022.101605
        PubMed      DOI
    6.Development of novel DNAJB6-KIAA1522-p-mTOR three-protein prognostic prediction models for CRC

    Author: Jiang, Yu-Juan; Zhang, Tong-Tong; Zhu, Yi-Qing; Cai, Hong-Qing; Chang, Chen; Hao, Jia-Jie; Cai, Yan; Wang, Ming-Rong; Liang, Jian-Wei; Zhang, Yu
    Journal: TRANSLATIONAL ONCOLOGY. 2023; Vol. 28, Issue , pp. -. DOI: 10.1016/j.tranon.2022.101609
        PubMed      DOI
    7.Expression of glucose transporter-1 in follicular lymphoma affected tumor-infiltrating immunocytes and was related to progression of disease within 24 months

    Author: Deng, Yuwei; Ma, Jianli; Zhao, Shu; Yang, Ming; Sun, Yutian; Zhang, Qingyuan
    Journal: TRANSLATIONAL ONCOLOGY. 2023; Vol. 28, Issue , pp. -. DOI: 10.1016/j.tranon.2022.101614
        PubMed      DOI
    8.Multiregion single cell analysis reveals a novel subtype of cancer-associated fibroblasts located in the hypoxic tumor microenvironment in colorectal cancer

    Author: Zheng, Nanxin; Wen, Rongbo; Zhou, Leqi; Meng, Qingying; Zheng, Kuo; Li, Zhixuan; Cao, Fuao; Zhang, Wei
    Journal: TRANSLATIONAL ONCOLOGY. 2023; Vol. 27, Issue , pp. -. DOI: 10.1016/j.tranon.2022.101570
        PubMed      DOI
    9.Identification and Validation of Novel Immunogenic Cell Death- and DNA Damage Response-Related Molecular Patterns Correlated with Immune Status and Prognosis in Hepatocellular Carcinoma

    Author: Zhang, Xiaokai; Wen, Jie; Zhang, Guixiong; Fan, Wenzhe; Tan, Jizhou; Liu, Haikuan; Li, Jiaping
    Journal: TRANSLATIONAL ONCOLOGY. 2023; Vol. 27, Issue , pp. -. DOI: 10.1016/j.tranon.2022.101600
        PubMed      DOI
    10.Effect of transmembrane protein 100 on prostate cancer progression by regulating SCNN1D through the FAK/PI3K/AKT pathway

    Author: Ye, Zehua; Xia, Yuqi; Li, Lei; Li, BoJun; Chen, Wu; Han, Shangting; Zhou, Xiangjun; Chen, Lijia; Yu, Weimin; Ruan, Yuan; Cheng, Fan
    Journal: TRANSLATIONAL ONCOLOGY. 2023; Vol. 27, Issue , pp. -. DOI: 10.1016/j.tranon.2022.101578
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144642.90
    LANCET700133.20
    NEW ENGLAND JOURNAL OF MEDICINE933134.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION62245.40
    NATURE REVIEWS DRUG DISCOVERY289123.80
    BMJ-British Medical Journal015.30
    BMJ-British Medical Journal015.30
    NATURE REVIEWS IMMUNOLOGY35183.00
    NATURE MEDICINE497107.50
    Nature Reviews Disease Primers4860.90
    同分区等级的其他期刊名称 h-index CiteScore
    Living Reviews in Relativity065.50
    Living Reviews in Relativity7565.50
    JOURNAL OF TRAVEL MEDICINE5119.60
    Military Medical Research030.10
    Advanced Composites and Hybrid Materials016.90
    INTERNATIONAL JOURNAL OF COMPUTER VISION17222.50
    Eurosurveillance9027.70
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE715.70
    Small Structures00.00
    Trends in Chemistry032.10


以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

    同领域作者分享投稿经验:共9条 (包含回复)

我来分享

    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海分公司    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960

    增值电信业务经营许可证:沪B2-20211595

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室

    United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451